InMed Pharmaceuticals Inc. (INM) Earnings
InMed Pharmaceuticals Inc.'s most recently reported earnings, recent earnings filings (8-K) and headline annual financials, sourced from SEC EDGAR.
Last reported earnings
Not available
From the latest earnings 8-K
Revenue • FY2026
$0
▼ 100.0%YoY
Diluted EPS • FY2026
$-3.12
▲ 62.7%YoY
Reported earnings dates are based on the latest 8-K (Item 2.02) filings. The next earnings date is an estimate projected from INM's historical reporting pattern, not a company-confirmed date.
Headline financials
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2026 | $0 | -$12.56M | — | $-3.12 | — | — | -100.0% |
| FY2025 | $4.94M | -$8.16M | $1.71M | $-8.36 | — | — | +7.5% |
| FY2024 | $4.6M | -$7.68M | $1.1M | $-1.01 | -$7M | — | +11.2% |
| FY2023 | $4.14M | -$7.95M | $1.4M | $-3.25 | -$7.44M | -192.2% | +202.8% |
Recent earnings filings
No earnings filings are available yet.
Never miss a INM filing.
Get an email when INM files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Oct 17, 2026Source: SEC EDGAR.